Arrhythmogenic potential of antiemetics: Perspectives on risk-benefits

Canadian Journal of Anesthesia

Volumn 50, Issue 3, 2003, Pages 215-220

  Miller, Donald R ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; DIMENHYDRINATE; DOLASETRON MESILATE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; HYDRODOLASETRON; METOCLOPRAMIDE; ONDANSETRON; PROCAINAMIDE; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR; VERAPAMIL;

ANESTHESIA; ARRHYTHMOGENESIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; LOW DRUG DOSE; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TORSADE DES POINTES;

EID: 0037359572     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017787     Document Type: Editorial

References (12)

1. Watcha MF. The cost-effective management of postoperative nausea and vomiting (Editorial). Anesthesiology 2000; 92: 931-3.
2. www.fda.gov/bbs/topics/answers/2001/ans01123.html
3. Bailey P. The FDA droperidol warning: Is it justified? (Letter) Anesthesiology 2002; 97: 288-9.
4. Tong JG, White PF, Scuderi PE, Watcha M, Kovac A. FDA "Black Box" warning regarding use of droperidol for postoperative nausea and vomiting: Is it justified? (Letter) Anesthesiology 2002; 97: 287.
5. Kasinath NS, Malak O, Tetzlaff J. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anesth 2002; 50: 229-31.
6. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295: 614-20.
7. Baguley WA, Hay WT, Mackie KP, Cheney FW, Cullen BF. Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997; 84: 1380-1.
8. Kovac AL, O'Connor TA, Pearman MH, et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth 1999; 11: 453-9.
9. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90: 186-94.
10. Chen JJ, Frame DG, White TJ. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip or total knee replacement procedures: a randomized double-blind comparative trial. Arch Int Med 1999; 159: 615-21.
11. Kranke P, Morin AM, Roewer N, Eberhart LH. Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthiol Scand 2002; 46: 238-44.
12. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999; 83: 761-7.